Company intelligence / Profile preview

Vipragen Biosciences

Ownership: Private
Development stage: Commercial

Overview

Vipragen Biosciences is a Contract Research Organization (CRO) providing a range of services to the pharmaceutical and biotech industries, primarily focusing on pre-clinical research including in vitro and in vivo studies, DMPK, toxicology, and efficacy studies across various therapeutic areas and modalities.

Modalities: Small moleculesAntibody-drug conjugates (ADCs)Cytotoxic chemical productsCell and gene therapies (support services)
Industry: Contract Research Organization

Beyond the preview

Go deeper on Vipragen Biosciences.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Vipragen Biosciences.

Explore the full profile